These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3708621)

  • 1. Phase II trial of esorubicin in advanced pancreatic adenocarcinoma.
    Blayney DW; Goldberg DA; Leong LA; Carr BI; Doroshow JH
    Cancer Treat Rep; 1986 May; 70(5):683-4. PubMed ID: 3708621
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW; Kemeny N
    Cancer Treat Rep; 1984; 68(7-8):1053-4. PubMed ID: 6744341
    [No Abstract]   [Full Text] [Related]  

  • 3. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Bartolucci A
    Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Birch R
    Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.
    Vaughn CB; Salmon SE; Fleming TR
    Invest New Drugs; 1990 Feb; 8(1):81-5. PubMed ID: 2188929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
    Fennelly D; Kelsen DP
    Hepatogastroenterology; 1996; 43(8):356-62. PubMed ID: 8714228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.
    Ajani JA; Kelsen DP; Haller D; Hargraves K; Healey D
    Cancer J; 2000; 6(2):78-81. PubMed ID: 11069223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of esorubicin in patients with advanced melanoma.
    Frustaci S; Gasparini G; Galligioni E; Tirelli U; Di Pietro N; Crivellari D; Lo Re G; Monfardini S
    Cancer Treat Rep; 1987 Mar; 71(3):325-6. PubMed ID: 3815399
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of doxorubicin therapy for advanced islet cell carcinoma.
    Moertel CG; Lavin PT; Hahn RG
    Cancer Treat Rep; 1982 Jul; 66(7):1567-9. PubMed ID: 6284361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial imaging with Cc-99m pyrophosphate in patients on adriamycin treatment for neoplasia.
    Chacko AK; Gordon DH; Bennett JM; O'Mara RE; Wilson GA
    J Nucl Med; 1977 Jul; 18(7):680-3. PubMed ID: 194931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
    Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
    Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1987 Sep; 71(9):865-7. PubMed ID: 3476203
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer.
    Stanton GF; Raymond V; Wittes RE; Schulman P; Budman D; Baratz R; Williams L; Petroni GR; Geller NL; Hancock C
    Cancer Res; 1985 Apr; 45(4):1862-8. PubMed ID: 3978646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of curcumin in patients with advanced pancreatic cancer.
    Dhillon N; Aggarwal BB; Newman RA; Wolff RA; Kunnumakkara AB; Abbruzzese JL; Ng CS; Badmaev V; Kurzrock R
    Clin Cancer Res; 2008 Jul; 14(14):4491-9. PubMed ID: 18628464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
    Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.